Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Synergy Pharma (SGYP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 481,143
  • Shares Outstanding, K 246,740
  • Annual Sales, $ 16,820 K
  • Annual Income, $ -224,340 K
  • 36-Month Beta 1.23
  • Price/Sales 27.73
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.55 +21.94%
on 05/31/18
2.10 -10.00%
on 06/21/18
+0.28 (+17.39%)
since 05/22/18
3-Month
1.42 +32.63%
on 05/02/18
2.10 -10.00%
on 06/21/18
-0.02 (-1.05%)
since 03/22/18
52-Week
1.42 +32.63%
on 05/02/18
4.84 -60.95%
on 06/26/17
-2.70 (-58.82%)
since 06/22/17

Most Recent Stories

More News
Synergy Pharmaceuticals Announces Amendment to CRG Debt Agreement

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that it...

SGYP : 1.89 (-3.08%)
Allergan Requests Shareholders to Veto Management Change

Allergan (AGN) responds to shareholders stating that it is open to the latter's opinions. However, the company has requested them to vote against appointment of independent chairman.

MYL : 38.31 (-0.83%)
AGN : 173.42 (+0.54%)
SHPG : 161.85 (-0.34%)
SGYP : 1.89 (-3.08%)
Today's Research Reports on Trending Tickers: Synergy Pharmaceuticals and Mylan N.V.

NEW YORK, NY / ACCESSWIRE / June 6, 2018 / Major indexes closed mostly higher Tuesday, lifted by a rally from the technology sector. The Dow Jones Industrial Average decreased 0.06 percent to close at...

SGYP : 1.89 (-3.08%)
Synergy Pharmaceuticals to Present New Analysis of Therapeutic Risk and Benefit of TRULANCE(R) (plecanatide) and Linaclotide in Chronic Idiopathic Constipation (CIC) Patients at Digestive Disease Week (DDW)

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that the...

SGYP : 1.89 (-3.08%)
Synergy Pharmaceuticals Highlights New Data at Digestive Disease Week (DDW) 2018 Linking Uroguanylin Deficiency to Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome with Constipation (IBS-C)

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, announced today new data...

SGYP : 1.89 (-3.08%)
Implied Volatility Surging for Synergy Pharmaceuticals (SGYP) Stock Options

Investors need to pay close attention to Synergy Pharmaceuticals (SGYP) stock based on the movements in the options market lately.

SGYP : 1.89 (-3.08%)
Look for Shares of Synergy Pharmace to Potentially Rebound after Yesterday's 1.53% Sell Off

Synergy Pharmace (NASDAQ:SGYP) traded in a range yesterday that spanned from a low of $1.43 to a high of $1.65. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $1.50...

SGYP : 1.89 (-3.08%)
Synergy Pharmaceuticals Reports First Quarter 2018 Financial Results and Business Update

--Synergy lowers 2018 adjusted operating expense (non-GAAP) guidance

SGYP : 1.89 (-3.08%)
Synergy Pharmaceuticals to Report First Quarter 2018 Financial Results and Host Conference Call and Webcast

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced it intends...

SGYP : 1.89 (-3.08%)
Options Traders Expect Huge Moves in Synergy Pharmaceuticals (SGYP) Stock

Investors in Synergy Pharmaceuticals (SGYP) need to pay close attention to the stock based on moves in the options market lately.

SGYP : 1.89 (-3.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More Share

Trade SGYP with:

Business Summary

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. Its lead drug candidate plecanatide is a guanylyl cyclase C receptor agonist, to treat GI disorders, primarily chronic constipation and constipation-predominant-...

See More

Key Turning Points

2nd Resistance Point 2.13
1st Resistance Point 2.01
Last Price 1.89
1st Support Level 1.81
2nd Support Level 1.73

See More

52-Week High 4.84
Fibonacci 61.8% 3.54
Fibonacci 50% 3.13
Fibonacci 38.2% 2.73
Last Price 1.89
52-Week Low 1.42

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar